|
Q2 FY2022
As of Jul 31, 2021
|
Q1 FY2022
As of Apr 30, 2021
|
Q4 FY2021
As of Jan 31, 2021
|
Q3 FY2021
As of Oct 31, 2020
|
Q2 FY2021
As of Jul 31, 2020
|
Q1 FY2021
As of Apr 30, 2020
|
Q4 FY2020
As of Jan 31, 2020
|
Q3 FY2020
As of Oct 31, 2019
|
Q2 FY2020
As of Jul 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Marketable securities | |||||||||
| Trade and other receivables, net | |||||||||
| Deferred commissions, current | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Total current assets | |||||||||
| Property and equipment, net | |||||||||
| Deferred commissions, noncurrent | |||||||||
| Goodwill and intangible assets, net | |||||||||
| Property and equipment, net | |||||||||
| Operating lease right-of-use assets | |||||||||
| Deferred commissions, noncurrent | |||||||||
| Goodwill | |||||||||
| Intangible assets, net | |||||||||
| Other noncurrent assets | |||||||||
| Total assets | |||||||||
| Liabilities and stockholders' equity | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | |||||||||
| Accrued expenses and other current liabilities | |||||||||
| Accrued compensation | |||||||||
| Revolving line of credit | |||||||||
| Deferred revenue, current | |||||||||
| Total current liabilities | |||||||||
| Convertible senior notes, net | |||||||||
| Deferred revenue, noncurrent | |||||||||
| Deferred rent, noncurrent | |||||||||
| Lease liability, noncurrent | |||||||||
| Other liabilities | |||||||||
| Total liabilities | |||||||||
| Stockholders' equity: | |||||||||
| Preferred stock | |||||||||
| Common stock, $0.001 par value: 1,000,000,000 shares authorized as of July 31, 2021 and January 31, 2021; 160,601,679 shares and 154,995,819 shares issued and outstanding as of July 31, 2021 and January 31, 2021, respectively | |||||||||
| Common Class A | |||||||||
| Common Class B | |||||||||
| Common Stock | |||||||||
| Total common stock, $0.001 par value: 1,000,000,000 shares authorized as of July 31, 2021 and January 31, 2021; 160,601,679 shares and 154,995,819 shares issued and outstanding as of July 31, 2021 and January 31, 2021, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated other comprehensive income (loss) | |||||||||
| Accumulated deficit | |||||||||
| Common Stock | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities and stockholders' equity |
Loading...
